- Home
- CCIX vs SENS Comparison
CCIX vs SENS Comparison
Compare CCIX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIX
- SENS
- Stock Information
- Founded
- CCIX 2023
- SENS 1996
- Country
- CCIX United States
- SENS United States
- Employees
- CCIX N/A
- SENS N/A
- Industry
- CCIX
- SENS Industrial Machinery/Components
- Sector
- CCIX
- SENS Industrials
- Exchange
- CCIX Nasdaq
- SENS Nasdaq
- Market Cap
- CCIX 394.1M
- SENS 384.7M
- IPO Year
- CCIX 2024
- SENS N/A
- Fundamental
- Price
- CCIX $10.75
- SENS $0.66
- Analyst Decision
- CCIX
- SENS Strong Buy
- Analyst Count
- CCIX 0
- SENS 1
- Target Price
- CCIX N/A
- SENS $2.00
- AVG Volume (30 Days)
- CCIX 22.0K
- SENS 6.8M
- Earning Date
- CCIX 01-01-0001
- SENS 03-03-2025
- Dividend Yield
- CCIX N/A
- SENS N/A
- EPS Growth
- CCIX N/A
- SENS N/A
- EPS
- CCIX N/A
- SENS N/A
- Revenue
- CCIX N/A
- SENS $22,472,000.00
- Revenue This Year
- CCIX N/A
- SENS $58.74
- Revenue Next Year
- CCIX N/A
- SENS $33.51
- P/E Ratio
- CCIX N/A
- SENS N/A
- Revenue Growth
- CCIX N/A
- SENS 0.37
- 52 Week Low
- CCIX $10.00
- SENS $0.25
- 52 Week High
- CCIX $11.17
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- CCIX N/A
- SENS 42.39
- Support Level
- CCIX N/A
- SENS $0.57
- Resistance Level
- CCIX N/A
- SENS $0.78
- Average True Range (ATR)
- CCIX 0.00
- SENS 0.05
- MACD
- CCIX 0.00
- SENS 0.01
- Stochastic Oscillator
- CCIX 0.00
- SENS 44.04
About CCIX Churchill Capital Corp IX Ordinary Shares
Churchill Capital Corp IX is a blank check company.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.